P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS

• A. Steer,
• D. Chemlal,
• E. Varlet,
• A. Machura,
• A. Kassambara,
• E. Alaterre,
• G. Requirand,
• N. Robert,
• C. Hirtz,
• H. De Boussac,
• A. Bruyer,
• J. Moreaux

Affiliations

A. Steer

1 Diag2Tec

D. Chemlal

1 Diag2Tec

E. Varlet

2 Institute of Human Genetics, UMR 9002 CNRS-UM

A. Machura

1 Diag2Tec

A. Kassambara

1 Diag2Tec

E. Alaterre

2 Institute of Human Genetics, UMR 9002 CNRS-UM

G. Requirand

3 Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, CHU Montpellier

N. Robert

3 Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, CHU Montpellier

C. Hirtz

4 Clinical Proteomics Platform, LBPC, IRMB, CHU, UM Montpellier, Montpellier, France

H. De Boussac

1 Diag2Tec

A. Bruyer

1 Diag2Tec

J. Moreaux

2 Institute of Human Genetics, UMR 9002 CNRS-UM